Advanced search
Start date

Evaluation of transfection capacity into HEK cells of ferritin nanoparticles containing DNA vaccine

Grant number: 19/25430-4
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): July 01, 2020
Effective date (End): June 30, 2021
Field of knowledge:Health Sciences - Pharmacy - Pharmaceutical Technology
Principal researcher:Fabiana Testa Moura de Carvalho Vicentini
Grantee:Gisele Mitsue Umino
Home Institution: Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil


DNA vaccines are plasmid constructs designed to express a coded protein antigen after in vivo administration and subsequent transfection of cells and tissues of interest (LIU, 2011). A gene-based vaccine offers molecular precision with the flexibility to induce immune responses against varied target antigens. However, one of the major challenges for effective use of DNA vaccines is choosing which approach to use to stimulate the immune system, in other words, using strategies to make DNA vaccines more immunogenic. In this context, the nanotechnology offers multiple platforms that can be used as adjuvants for this new generation of vaccines, enabling the ability to rationally design nanomaterials with specific surface size, shape, morphology and functionality. It is also possible to have the added benefit of choosing from various types of biodegradable and biocompatible materials (MAMO; POLAND, 2012). The present project is part of a project entitled: "Use of ferritin nanoparticles as a basis for the development of antitumor vaccine delivery systems" (FAPESP Process n° 2019/08891-8) under the coordination of Profa. Dr. Fabiana T.M.C. Vicentini. Considering the impact of the cellular uptake process for the efficacy of DNA vaccines, the evaluation of the developed systems behavior in the cell transfection process and the consequent formation of the protein of interest in HEK cells, the main objective of this project, becomes a crucial step for the understanding and selection of the best formulations to be employed in future immunogenicity studies.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items